Halozyme Therapeutics Inc. (HALO)

Halozyme Therapeutics Inc. (HALO $81.23)
- $81.23 P/E (TTM): 17.1X Cap: $9.55B
- View HALO Profile
- View Questions on HALO

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Intuitive Surgical Inc. (ISRG $488.15)
- $488.15 P/E (TTM): 64.48X Cap: $173.35B
- View ISRG Profile
- View Questions on ISRG
Vertex Pharmaceuticals Incorporated (VRTX $477.92)
- $477.92 P/E (TTM): 33.42X Cap: $121.25B
- View VRTX Profile
- View Questions on VRTX
AbbVie Inc. (ABBV $223.43)
- $223.43 P/E (TTM): 170.56X Cap: $394.88B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $239.99)
- $239.99 P/E (TTM): 23.17X Cap: $578.20B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $1,058.18)
- $1,058.18 P/E (TTM): 51.77X Cap: $1T
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $121.93)
- $121.93 P/E (TTM): 16.12X Cap: $302.63B
- View MRK Profile
- View Questions on MRK
iShares Biotechnology ETF (IBB $174.98)
- $174.98 P/E (TTM): 20.63X Cap: $8.66B
- View IBB Profile
- View Questions on IBB
IDEXX Laboratories Inc. (IDXX $644.61)
- $644.61 P/E (TTM): 51.12X Cap: $51.47B
- View IDXX Profile
- View Questions on IDXX
Halozyme Therapeutics Inc. (HALO $81.23)
- $81.23 P/E (TTM): 17.1X Cap: $9.55B
- View HALO Profile
- View Questions on HALO
Incyte Corporation (INCY $108.39)
- $108.39 P/E (TTM): 18.53X Cap: $21.27B
- View INCY Profile
- View Questions on INCY
Catalyst Pharmaceuticals Inc. (CPRX $24.44)
- $24.44 P/E (TTM): 14.21X Cap: $3B
- View CPRX Profile
- View Questions on CPRX
Gilead Sciences CDR (CAD Hedged) (GILD $31.27)
- $31.27 P/E (TTM): 401.32X Cap: $258.69B
- View GILD Profile
- View Questions on GILD

Q: We have accumulated 11 healthcare stocks and 1 ETF, While LLY and ISRG are at half positions the rest are at initial 25% positions. Please advise [help!] us get to a more concentrated portfolio with a 3+ year horizon for reasonable opportunities in healthcare

Read Answer Asked by sam on January 13, 2026

Alphabet Inc. (GOOG $323.10)
- $323.10 P/E (TTM): 29.89X Cap: $3.90T
- View GOOG Profile
- View Questions on GOOG
Pure Storage Inc. Class A (PSTG $70.99)
- $70.99 P/E (TTM): 182.03X Cap: $23.43B
- View PSTG Profile
- View Questions on PSTG
CECO Environmental Corp. (CECO $72.37)
- $72.37 P/E (TTM): 50.96X Cap: $2.57B
- View CECO Profile
- View Questions on CECO
e.l.f. Beauty Inc. (ELF $82.09)
- $82.09 P/E (TTM): 57.81X Cap: $4.84B
- View ELF Profile
- View Questions on ELF
Halozyme Therapeutics Inc. (HALO $81.23)
- $81.23 P/E (TTM): 17.1X Cap: $9.55B
- View HALO Profile
- View Questions on HALO
Genius Sports Limited (GENI $6.09)
- $6.09 Cap: $1.46B
- View GENI Profile
- View Questions on GENI
Nebius Group N.V. (NBIS $86.10)
- $86.10 Cap: $20.50B
- View NBIS Profile
- View Questions on NBIS

Q: Hi Team,
I was looking for quality growth names that were attractive today for purchase. Geni was on the list due to the recent weakness in the sports betting sector. Do you see it as a opportunity to buy at these levels? Could you also provide a couple names on your radar either cnd or US that you see as particular good buys today for a 10yr hold? Thanks

Shane.

Read Answer Asked by Shane on October 10, 2025

AbbVie Inc. (ABBV $223.43)
- $223.43 P/E (TTM): 170.56X Cap: $394.88B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $1,058.18)
- $1,058.18 P/E (TTM): 51.77X Cap: $1T
- View LLY Profile
- View Questions on LLY
Cipher Pharmaceuticals Inc. (CPH $14.40)
- $14.40 P/E (TTM): 15.45X Cap: $365M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
Halozyme Therapeutics Inc. (HALO $81.23)
- $81.23 P/E (TTM): 17.1X Cap: $9.55B
- View HALO Profile
- View Questions on HALO
uniQure N.V. (QURE $25.65)
- $25.65 Cap: $1.53B
- View QURE Profile
- View Questions on QURE
Catalyst Pharmaceuticals Inc. (CPRX $24.44)
- $24.44 P/E (TTM): 14.21X Cap: $3B
- View CPRX Profile
- View Questions on CPRX

Q: Hi, could you suggest a couple each of your fav. small, mid and large cap biotech stocks and why you like them.

thanks, M

Read Answer Asked by Mark on October 08, 2025